Cadila Healthcare gains on reporting rise in Q3 consolidated net profit

11 Feb 2015 Evaluate

Cadila Healthcare is currently trading at Rs. 1524.50, up by 10.55 points or 0.70% from its previous closing of Rs. 1513.95 on the BSE.

The scrip opened at Rs. 1524.00 and has touched a high and low of Rs. 1543.00 and Rs. 1520.05 respectively. So far 7281 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1760.00 on 11-Nov-2014 and a 52 week low of Rs. 872.55 on 19-May-2014.

Last one week high and low of the scrip stood at Rs. 1560.00 and Rs. 1425.10 respectively. The current market cap of the company is Rs. 31320.38 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 14.65% and 10.56% respectively.

Cadila Healthcare has reported a rise of 85.28% in its net profit at Rs 361.16 crore for the quarter under review as compared to Rs 194.93 crore for the same quarter in the previous year. Total income of the company increased by 35.64% at Rs 1475.06 crore for Q3FY15 as compared Rs 1087.48 crore for the corresponding quarter previous year.

On the consolidated basis the company’s net profit rose 51.59% to Rs 281.91 crore for the Q3 FY15, as compared to Rs 185.97 crore in Q3 FY14. Moreover, the total income increased 16.72% to Rs 2199.47 crore in the quarter under review as compared to Rs 1884.47 crore in the corresponding quarter previous year.

 

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×